Inspire Investing LLC Sells 139,220 Shares of Agilon Health, Inc. $AGL

Inspire Investing LLC trimmed its holdings in shares of Agilon Health, Inc. (NYSE:AGL) by 64.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,330 shares of the company’s stock after selling 139,220 shares during the quarter. Inspire Investing LLC’s holdings in Agilon Health were worth $339,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of AGL. Nisa Investment Advisors LLC lifted its holdings in shares of Agilon Health by 244.9% during the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock worth $41,000 after purchasing an additional 6,783 shares during the period. Gabelli Funds LLC acquired a new position in Agilon Health during the 1st quarter worth about $48,000. Ridgecrest Wealth Partners LLC bought a new stake in shares of Agilon Health in the 1st quarter valued at about $65,000. Pallas Capital Advisors LLC bought a new position in shares of Agilon Health during the first quarter worth about $66,000. Finally, Captrust Financial Advisors lifted its stake in shares of Agilon Health by 10.9% in the fourth quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock worth $67,000 after acquiring an additional 3,494 shares during the period.

Agilon Health Price Performance

Shares of Agilon Health stock opened at $1.14 on Thursday. The business has a 50-day simple moving average of $1.47 and a 200 day simple moving average of $2.71. Agilon Health, Inc. has a one year low of $0.71 and a one year high of $6.08. The firm has a market capitalization of $472.44 million, a price-to-earnings ratio of -1.48 and a beta of 0.11.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The firm had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the business posted ($0.07) EPS. The company’s revenue was down 5.9% on a year-over-year basis. On average, sell-side analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Benchmark lowered their price target on shares of Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a report on Wednesday, August 6th. Jefferies Financial Group dropped their target price on shares of Agilon Health from $2.40 to $1.10 and set a “hold” rating on the stock in a report on Friday, August 15th. Barclays cut their price target on shares of Agilon Health from $3.00 to $1.50 and set an “underweight” rating on the stock in a research report on Wednesday, August 6th. Sanford C. Bernstein reissued a “market perform” rating and issued a $1.40 price objective (down from $4.00) on shares of Agilon Health in a research report on Wednesday, August 20th. Finally, Robert W. Baird cut their target price on Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a research report on Thursday, August 14th. Four analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $3.07.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.